4.5 Article

Multifarious proteomic signatures and regional heterogeneity in glioblastomas

期刊

JOURNAL OF NEURO-ONCOLOGY
卷 94, 期 1, 页码 31-39

出版社

SPRINGER
DOI: 10.1007/s11060-009-9805-8

关键词

Proteomics; Mass spectrometry; Glioblastoma; Heterogeneity; Ubiquitin carboxyl-terminal esterase L1; Transthyretin

资金

  1. Korea government (MEST) [R01-2008-000-20268-0]
  2. Seoul National University Hospital Research Fund [04-2008-095]
  3. National Research Foundation of Korea [R01-2008-000-20268-0] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

To investigate the underlying intratumoral diversity of molecular profiles in glioblastomas, a proteomic approach was introduced to compare samples from regions of different histological grade. Using two-dimensional gel electrophoresis (2DE) with matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), we compared prospectively collected tissue samples of different histological grade areas of three glioblastoma patients. Consistent results showing relatively high expression of ubiquitin carboxyl-terminal esterase L1 in low-histological-grade areas (Grade 2 > Grades 3 and 4) and high expression of transthyretin in high-histological-grade areas (Grade 2 < Grades 3 and 4) were demonstrated. These results were confirmed by western blot (WB) analysis and immunohistochemical staining. This study provided the evidence of multifarious proteomic signatures according to regional and histological heterogeneity in glioblastomas.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

MYB/MYBL1::QKI fusion-positive diffuse glioma

Ye Yoon Suh, Kwanghoon Lee, Yu-Mi Shim, Ji Hoon Phi, Chul-Kee Park, Seung-Ki Kim, Seung Hong Choi, Hongseok Yun, Sung-Hye Park

Summary: The MYB/MYBL1::QKI fusion activates the oncogene MYB and deletes the tumor suppressor gene QKI. Previously, this fusion was only reported in angiocentric glioma (AG) and diffuse low-grade glioma. This study compares two tumors with the MYB/MYBL1::QKI fusion: a diffuse pediatric-type high-grade glioma (DPedHGG) in an 11-year-old boy and an AG in a 46-year-old woman. Characterization using immunohistochemistry, next-generation sequencing, and methylation profiling reveals their molecular characteristics and supports the presence of MYB/MYBL1 alterations in higher-grade gliomas.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2023)

Editorial Material Clinical Neurology

Announcing the Asian Oceanian Society of Neuropathology guidelines for Adapting Diagnostic Approaches for Practical Taxonomy in Resource-Restrained Regions (AOSNP-ADAPTR)

M. E. Buckland, C. Sarkar, V. Santosh, M. Al-Hussaini, S. H. Park, T. Tihan, H. K. Ng, T. Komori

BRAIN PATHOLOGY (2023)

Article Clinical Neurology

Fibrous hamartoma of infancy of the spinal cord resembling conus and filum, with a coexisting sacral dimple

Tae-Hwan Park, Kyung Hyun Kim, Seung-Ki Kim, Kyu-Chang Wang, Sung-Hye Park, Ji Yeoun Lee

Summary: Fibrous hamartoma of infancy (FHI) is a rare benign soft tissue lesion that usually occurs in infants and young children within the first 2 years of life. FHI in the central nervous system (CNS) is extremely rare, with only two cases of spinal cord FHI reported so far. We present a unique case of FHI in a 1-month-old girl with a skin dimple in the coccygeal area, where both a skin lesion and an intramedullary mass were diagnosed as FHI. Despite being diagnosed with a neurogenic bladder, the patient maintained normal neurological function and showed good mobility during the 5.5-year follow-up period.

CHILDS NERVOUS SYSTEM (2023)

Review Clinical Neurology

Neuroepithelial tumor with EWSR1::PATZ1 fusion: A literature review

Hyunhee Kim, Kwanghoon Lee, Ji Hoon Phi, Sun Ha Paek, Hongseok Yun, Seung Hong Choi, Sung-Hye Park

Summary: This study presents the clinicopathological and molecular genetic characteristics of a neuroepithelial tumor (NET) with EWSR1::PATZ1 fusion, which has recently been discovered in rare central nervous system tumors and soft tissue sarcomas. Two cases of this fusion were identified, with the pediatric case showing a high-grade tumor and longer survival compared to conventional glioblastoma. The TERT promoter mutation may serve as an indicator of high-grade behavior in PATZ1 fusion NET.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2023)

Article Medicine, Research & Experimental

Epigenetic Alteration of H3K27me3 as a Possible Oncogenic Mechanism of Central Neurocytoma

Hyunhee Kim, Kwanghoon Lee, Yu -Mi Shim, Eric Eunshik Kim, Seung-Ki Kim, Ji Hoon Phi, Chul-Kee Park, Seung Hong Choi, Sung-Hye Park

Summary: Central neurocytoma is a low-grade neuronal tumor that mainly occurs in the lateral ventricle, and the genetic abnormalities that cause this tumor are poorly understood. Through the study of immunomarkers in fetal and adult brains, as well as supratentorial periventricular tumors, the biomarkers, cell of origin, and tumorigenesis of central neurocytoma were characterized. Immunohistochemical analysis showed that central neurocytomas were positive for certain markers, including FGFR3, SSTR2, TTF-1, GLUT-1, and L1CAM.

LABORATORY INVESTIGATION (2023)

Article Oncology

Added prognostic value of 3D deep learning-derived features from preoperative MRI for adult-type diffuse gliomas

Jung Oh Lee, Sung Soo Ahn, Kyu Sung Choi, Junhyeok Lee, Joon Jang, Jung Hyun Park, Inpyeong Hwang, Chul-Kee Park, Sung Hye Park, Jin Wook Chung, Seung Hong Choi

Summary: This study investigated the prognostic value of spatial features from whole-brain MRI using a three-dimensional convolutional neural network for adult-type diffuse gliomas. The results showed that the MRI-based prognostic index model had good predictive performance, and combining clinical, molecular genetic, and imaging data improved the performance of the prediction model.

NEURO-ONCOLOGY (2023)

Article Oncology

Clinicogenetic characteristics and the effect of radiation on the neural stem cell niche in subventricular zone-contacting glioblastoma

Jee Ye Kahng, Byung-Hee Kang, Soon-Tae Lee, Seung Hong Choi, Tae Min Kim, Chul-Kee Park, Jae-Kyung Won, Sung-Hye Park, Jaeman Son, Joo Ho Lee

Summary: This study investigated the relationship between neural stem cells (NSCs) in the subventricular zone (SVZ) and glioblastoma (GBM), as well as the impact of radiotherapeutic strategies. The results showed that GBM patients without SVZ involvement had longer progression-free survival, while patients with GBM in contact with NSCs showed better prognosis after NSC irradiation. This study is of great significance for understanding the origin and treatment of GBM.

RADIOTHERAPY AND ONCOLOGY (2023)

Article Oncology

A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification

Seung Won Choi, Hyun Ae Jung, Hee-Jin Cho, Tae Min Kim, Chul-Kee Park, Do-Hyun Nam, Se-Hoon Lee

Summary: This study evaluated the therapeutic efficacy of the novel anti-EGFR monoclonal antibody GC1118 in recurrent GBM patients with EGFR amplification. Although the study did not meet the primary endpoint, it was found that immune-related signatures were significantly upregulated in tumors with regression upon GC1118 therapy, indicating the potential immune-mediated antitumor efficacy of GC1118.

CANCER MEDICINE (2023)

Correction Multidisciplinary Sciences

Patient-derived glioblastoma cell lines with conserved genome profiles of the original tissue (vol 10, 448, 2023)

Soon-Chan Kim, Young-Eun Cho, Young-Kyoung Shin, Hyeon Jong Yu, Tamrin Chowdhury, Sojin Kim, Kyung Sik Yi, Chi-Hoon Choi, Sang-Hoon Cha, Chul-Kee Park, Ja-Lok Ku

SCIENTIFIC DATA (2023)

Article Multidisciplinary Sciences

Patient-derived glioblastoma cell lines with conserved genome profiles of the original tissue

Soon-Chan Kim, Young-Eun Cho, Young-Kyoung Shin, Hyeon Jong Yu, Tamrin Chowdhury, Sojin Kim, Kyung Sik Yi, Chi-Hoon Choi, Sang-Hoon Cha, Chul-Kee Park, Ja-Lok Ku

Summary: Glioblastoma (GBM) is a deadly intracranial tumor. Sequencing technologies have helped in personalized therapy for GBM, but in vitro and in vivo models are needed to validate in silico evaluations of genomic features. GBM cell lines with whole exome sequencing (WES) datasets of matched tumor tissues and blood can be used to investigate molecular markers and validate druggable targets. A complete WES dataset of 26 GBM patient-derived cell lines along with their matched tumor tissues and blood is provided to show that cell lines can largely recapitulate genomic profiles of original tumors.

SCIENTIFIC DATA (2023)

Article Biochemistry & Molecular Biology

Enrichment of Deleterious Mutated Genes Involved in Ciliary Function and Histone Modification in Brain Cancer Patient-Derived Xenograft Models

Hyeongsun Jeong, Hyo Eun Moon, Seongmin Yun, Seung Woo Cho, Hye Ran Park, Sung-Hye Park, Kyungjae Myung, Taejoon Kwon, Sun Ha Paek

Summary: In this study, 13 PDX models derived from 11 brain tumor patients were established. It was found that PDX samples were enriched with brain tumor-related genes and had distinct mutation profiles compared to the original tumors, indicating mutational alterations occurring in the xenograft environment.

BIOMEDICINES (2023)

Article Engineering, Biomedical

Validation of real-time inside-out tracking and depth realization technologies for augmented reality-based neuronavigation

Yun-Sik Dho, Byeong Cheol Lee, Hyeong Cheol Moon, Kyung Min Kim, Ho Kang, Eun Jung Lee, Min-Sung Kim, Jin Wook Kim, Yong Hwy Kim, Sang Joon Park, Chul-Kee Park

Summary: Concomitant with advances in computing technology, augmented reality-based navigation in clinical applications is being researched. Novel object tracking and depth realization technologies were developed for augmented reality-based neuronavigation in brain surgery. The results validate the efficacy of these technologies in overcoming critical obstacles in the development of clinically applicable augmented reality neuronavigation.

INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY (2023)

Review Clinical Neurology

Korean Brain Tumor Society Consensus Review for the Practical Recommendations on Glioma Management in Korea

Chul-Kee Park, Jong Hee Chang

Summary: Recent updates in genomic-integrated glioma classification have caused confusion in clinical practice, but the Korean Brain Tumor Society conducted a questionnaire survey to gain consensus on risk group categorization and treatment preferences. They found agreement on dichotomic definition of risk groups and consistent decisions based on WHO grade and risk group for treatment protocols. Temporary consensus and available options will aid management until more evidence is accumulated under the new classification system.

JOURNAL OF KOREAN NEUROSURGICAL SOCIETY (2023)

Review Medicine, General & Internal

Brain Tumor Classification by Methylation Profile

Jin Woo Park, Kwanghoon Lee, Eric Eunshik Kim, Seong-Ik Kim, Sung-Hye Park

Summary: The methylation classifier is a tool used to accurately classify brain tumors based on their methylation profiles. It helps healthcare professionals predict tumor prognosis and establish personalized treatment plans. However, it has limitations in classifying all types of brain tumors and faces challenges in obtaining reference data and charging patients for its services.

JOURNAL OF KOREAN MEDICAL SCIENCE (2023)

暂无数据